influenza
virus
contain
singlestrand
rna
classifi
type
b
c
dolin
murray
et
al
treanor
viru
segment
envelop
nucleocapsid
type
subtyp
vari
type
hemagglutinin
subtyp
protein
import
host
cell
attach
antibodi
direct
hemagglutinin
provid
human
immun
infect
addit
viru
possess
either
neuraminidas
n
subtyp
also
assist
viral
entri
host
cell
elicit
product
neutral
antibodi
de
jong
et
al
influenza
highli
communic
diseas
transmit
aerosol
dropletnuclei
produc
cough
andor
sneez
direct
contact
age
group
suscept
infect
although
young
elderli
individu
chronic
medic
complic
compromis
pulmonari
cardiovascular
condit
kidney
impair
diabet
immunosuppress
disord
pregnant
women
nd
rd
trimest
increas
risk
although
reservoir
primarili
human
influenza
virus
document
pig
hors
seal
duck
chicken
whale
certain
subtyp
influenza
speci
specif
although
subtyp
document
bird
promin
human
subtyp
includ
influenza
viru
distinct
h
distinct
n
subtyp
although
promin
associ
diseas
outbreak
human
subtyp
influenza
virus
promin
one
speci
may
occas
infect
caus
diseas
anoth
exampl
subtyp
cross
human
pig
caus
seriou
diseas
swine
popul
addit
influenza
virus
bird
transmit
human
directli
indirectli
intermedi
host
way
genet
element
influenza
viru
may
reassort
form
new
subtyp
h
n
human
immun
schweiger
et
al
situat
worldwid
pandem
occur
document
instanc
avian
influenza
virus
infect
human
numer
influenza
singlestrand
rna
viru
caus
acut
highli
contagi
upper
respiratori
diseas
influenza
viru
member
famili
virus
term
orthomyxovirida
virus
singl
neg
strand
rna
consist
separ
segment
nucleocapsid
helic
viral
specif
rna
polymeras
influenza
virus
exit
cell
bud
host
cell
plasma
membran
envelop
possess
two
type
spike
protein
neuraminidas
n
hemagglutinin
activ
h
eman
lipid
envelop
viru
irregular
spheric
shape
measur
nm
diamet
influenza
ill
uncompl
otherwis
healthi
nonelderli
adult
fatal
occur
due
secondari
bacteri
infect
respiratori
tree
although
common
caus
bacteri
pneumonia
due
pneumococci
seriou
due
staphylococc
infect
haemophilu
influenza
streptococcu
pneumonia
streptococcu
pyogen
infrequ
caus
pneumonia
mortal
rate
higher
among
elderli
pregnant
women
medic
complic
influenza
infect
often
confus
common
cold
http
wwwniaidnihgov
factsheetscoldhtm
may
similar
sign
symptom
http
familydoctor
influenza
infect
resembl
numer
mild
febril
diseas
stand
due
cough
muscl
ach
malais
sudden
onset
differenti
diseas
includ
infect
caus
rsv
respiratori
syncyti
viru
adenovirus
rhinovirus
parainfluenza
virus
measl
viru
sever
acut
respiratori
syndrom
sar
coronaviru
mycoplasma
pneumonia
chlamydia
pneumonia
twar
agent
bordetella
pertussi
salmonella
typhi
streptococcu
pyogen
influenza
may
difficult
diagnos
absenc
epidem
etiolog
agent
influenza
flu
influenza
viru
three
type
viru
classifi
b
c
type
contain
singlestrand
rna
segment
packag
envelop
nucleocapsid
influenza
viru
spread
dropletnuclei
sneez
cough
patient
incid
parallel
upper
respiratori
infect
occur
northern
frigid
winter
month
late
autumn
earli
spring
influenza
epidem
cyclic
occur
everi
year
new
epidem
occur
antigen
drift
minor
chang
h
andor
n
antigen
therebi
allow
viru
avoid
immun
system
cdc
collect
report
relev
surveil
data
http
htm
influenza
viru
caus
necrosi
respiratori
epithelium
tracheobronchi
tree
nasal
turbin
desquam
ciliat
epithelium
edema
hyperemia
increas
secret
congest
may
therefor
result
secondari
bacteri
infect
laboratori
find
includ
leukopenia
often
proteinuria
influenza
viru
influenza
highli
contagi
diseas
mark
acut
onset
fever
f
sever
ach
pain
prostrat
inflamm
mucou
membran
respiratori
tract
sever
headach
addit
affect
individu
show
sign
coryza
nonproduct
cough
flush
face
sore
throat
children
nausea
vomit
otiti
media
often
report
fever
subsid
day
recoveri
usual
complet
one
week
although
malais
cough
may
continu
week
normal
incub
period
day
averag
day
adult
contagi
day
prior
symptom
day
onset
ill
immunocompromis
patient
shed
viru
week
month
treatment
influenza
infect
aim
control
viru
spread
immun
stohr
weycker
et
al
chemoprophylaxi
pregnant
women
compromis
patient
accomplish
amantadin
rimantadin
zanamivir
oseltamivir
hayden
schmidt
antipyret
analges
typic
use
symptomat
relief
fever
myalgia
older
nursinghom
resid
administ
mgday
rimantadin
reduct
dosag
mgday
consid
person
age
year
experi
possibl
side
effect
take
mgday
zanarnivir
administ
inhal
use
plastic
devic
includ
medic
packag
patient
benefit
instruct
demonstr
correct
use
devic
zanarnivir
approv
prophylaxi
reduct
dose
oseltamivir
recommend
person
creatinin
clearanc
mlmin
dose
recommend
children
weigh
kg
mg
twice
day
children
weigh
kg
dose
mg
twice
day
children
weigh
kg
dose
mg
twice
day
children
weigh
kg
dose
mg
twice
day
terminolog
influenza
virus
directli
relat
type
viru
origin
place
first
locat
year
discoveri
immun
invok
influenza
vaccin
gener
last
month
amantadin
amantadin
activ
influenza
virus
influenza
b
approv
chemoprophylaxi
treatment
chemoprophylaxi
influenza
type
viru
adult
children
year
age
amantadin
may
caus
central
nervou
system
side
effect
includ
anxieti
nervous
insomnia
light
headed
concentr
difficulti
gastrointestin
side
effect
includ
nausea
anorexia
dosag
mgday
effect
pregnant
women
fetus
unknown
use
pregnanc
potenti
benefit
justifi
risk
drug
resist
develop
approxim
onethird
patient
cross
resist
rimantadin
maximum
blood
level
attain
within
hour
administr
singl
mg
dose
peak
excret
rate
amantadin
mghr
mean
halflif
excret
rate
approxim
hour
clearanc
amantadin
reduc
adult
renal
insuffici
otherwis
healthi
elderli
adult
year
renal
clearanc
reduc
plasma
level
therefor
increas
drug
like
rimantidin
influenc
viral
uptak
prevent
membran
fusion
affect
matur
hemagglutinin
h
lower
infect
progeni
viru
effect
prevent
ill
healthi
adult
administ
prophylaxi
within
day
ill
reduc
flu
symptom
shorten
durat
ill
day
rimantadin
rimantadin
effect
influenza
influenza
b
virus
approv
treatment
chemoprophylaxi
influenza
infect
adult
prophylaxi
children
consid
appropri
treatment
diseas
children
rimantadin
may
caus
central
nervou
system
side
effect
includ
anxieti
nervous
insomnia
light
headed
concentr
difficulti
gastrointestin
side
effect
nausea
anorexia
dosag
mgday
effect
pregnant
women
fetus
unknown
use
pregnanc
potenti
benefit
justifi
risk
drug
resist
develop
approxim
onethird
patient
cross
resist
amantadin
rimantadin
effect
prevent
ill
healthi
adult
administ
prophylaxi
within
day
ill
reduc
flu
symptom
shorten
durat
ill
day
zanamivir
neuraminidas
inhibitor
activ
influenza
b
virus
approv
treatment
uncompl
influenza
infect
patient
age
year
guidelin
recommend
use
found
http
wwwcdcgovfluprofessionalstreat
effect
pregnant
women
fetus
unknown
use
pregnanc
potenti
benefit
justifi
risk
resist
zanamivir
treatment
may
occur
happen
frequent
oseltamivir
oseltamivir
neuraminidas
inhibitor
activ
influenza
b
virus
approv
treatment
uncompl
influenza
infect
patient
age
year
approv
chemoprophylaxi
influenza
infect
person
age
year
guidelin
recommend
use
found
http
wwwcdcgovflu
effect
pregnant
women
fetus
unknown
use
pregnanc
potenti
benefit
justifi
risk
resist
oseltamivir
treatment
may
occur
happen
frequent
nasal
spray
vaccin
bacteria
ferment
milk
incorpor
nasal
spray
use
prevent
treatment
influenza
mice
hori
et
al
kill
lactobacillu
casei
use
intranas
spray
stimul
immun
respons
respiratori
tract
treat
mice
onetenth
amount
viru
nasal
caviti
viru
challeng
result
four
time
greater
surviv
rate
mous
model
influenza
use
evalu
vaccin
antivir
drug
sidwel
smee
addit
ferret
natur
host
viru
ensu
ill
close
resembl
human
condit
maher
destefano
basic
inform
diagnosi
clinic
find
complic
prevent
treatment
influenza
includ
vaccin
safeti
recommend
found
http
inform
common
cold
flu
locat
http
xml
inform
common
cold
flu
locat
http
wwwniaidnih
govfactsheetscoldhtm
chapter
antivir
chemotherapi
found
http
chemohtm
detail
inform
influenza
virus
locat
http
comcontentaspx
searchstrinfluenzaaviru
